NCT03665064 2026-03-16Long Term Outcome Study in Patients With Pituitary DisordersUniversity of AlbertaActive not recruiting1,500 enrolled
NCT05199584 2026-03-05A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function MutationsEndeavor Biomedicines, Inc.Phase 2 Completed20 enrolled